TY - JOUR T1 - ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19 JF - Thorax JO - Thorax SP - 396 LP - 398 DO - 10.1136/thoraxjnl-2020-215818 VL - 76 IS - 4 AU - Swapna Mandal AU - Joseph Barnett AU - Simon E Brill AU - Jeremy S Brown AU - Emma K Denneny AU - Samanjit S Hare AU - Melissa Heightman AU - Toby E Hillman AU - Joseph Jacob AU - Hannah C Jarvis AU - Marc C I Lipman AU - Sindhu B Naidu AU - Arjun Nair AU - Joanna C Porter AU - Gillian S Tomlinson AU - John R Hurst A2 - , Y1 - 2021/04/01 UR - http://thorax.bmj.com/content/76/4/396.abstract N2 - Large numbers of people are being discharged from hospital following COVID-19 without assessment of recovery. In 384 patients (mean age 59.9 years; 62% male) followed a median 54 days post discharge, 53% reported persistent breathlessness, 34% cough and 69% fatigue. 14.6% had depression. In those discharged with elevated biomarkers, 30.1% and 9.5% had persistently elevated d-dimer and C reactive protein, respectively. 38% of chest radiographs remained abnormal with 9% deteriorating. Systematic follow-up after hospitalisation with COVID-19 identifies the trajectory of physical and psychological symptom burden, recovery of blood biomarkers and imaging which could be used to inform the need for rehabilitation and/or further investigation. ER -